The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
Boehringer Ingelheim (Brazil) · Boehringer Ingelheim (Japan) · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
825
total citations
- FWCI
- 53.26
- Percentile
- 100%
- References
- 17
Citations per year
Authors
10- PRPaul ReillyCorresponding
Boehringer Ingelheim (Brazil), Boehringer Ingelheim (Japan), Boehringer Ingelheim (United States)
- TLThorsten Lehr
Boehringer Ingelheim (Germany), Saarland University
- SHSebastian Haertter
Boehringer Ingelheim (Germany)
- SJStuart J. Connolly
Population Health Research Institute, McMaster University
- SYSalim Yusuf
Population Health Research Institute, McMaster University
Topics & keywords
Topics
Keywords
- Medicine
- Dabigatran
- Atrial fibrillation
- Stroke (engine)
- Cardiology
- Ischemic stroke
- Internal medicine
- Anesthesia
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.